Ambrisentan is a drug used to treat pulmonary arterial hypertension (PAH) that can improve exercise capacity and delay clinical deterioration. For patients who need to purchase this drug, it is very important to understand the formal purchasing channels.

How can Ambrisentan be purchased?

Ambrisentan has been launched in China and included in medical insurance. Patients can purchase it through a variety of channels, but they should pay attention to choosing formal channels to avoid the risk of counterfeit drugs.

Hospitals and formal pharmacies

Patients can purchase Ambrisentan with a doctor's prescription in large hospitals or formal pharmacies. The versions on the Chinese market may be original or generic drugs, and the prices vary depending on the region and medical insurance policy. It is recommended to consult the hospital pharmacy or pharmacy in advance to understand the inventory and price information.

Overseas drug purchase channels

The generic drug produced by Cipla in India has a specification of 5mg*10 tablets and costs about US$28 per box. Overseas drug purchases must be made through formal cross-border medical platforms or channels with legal qualifications, and pay attention to the transportation and storage conditions of drugs. The original packaging and complete instructions of the drug should be requested when purchasing.

Regardless of the channel through which the drug is purchased, patients should keep the receipt of purchase and check the manufacturer, batch number and expiration date on the drug packaging.

How to distinguish the authenticity of Ambrisentan

When purchasing Ambrisentan, it is crucial to distinguish between genuine and counterfeit products. The following methods can help patients identify the authenticity.

Packaging and appearance inspection

Authentic Ambrisentan tablets have two specifications: 5mg is light pink, biconvex, beveled, rounded square film-coated tablets, engraved with "APO" and "A5"; 10mg is dark pink, biconvex, oval film-coated tablets, engraved with "APO" and "A10". The packaging should be intact and undamaged, the label should be clear, and the printing should not be blurred or misplaced.

Drug traceability information

Regular drug packaging will have batch numbers, production dates and expiration dates, and some also provide anti-counterfeiting codes or traceability systems. Patients can query drug information through the manufacturer's official website or related platforms to confirm its authenticity.

If you find that the price is far lower than the market price or the packaging is abnormal when purchasing, you need to be vigilant. If necessary, suspicious drugs can be reported to the drug regulatory authorities.

Precautions for the use of Ambrisentan by men and women with reproductive potential

Ambrisentan has special requirements for people with reproductive potential, and patients must strictly follow the following precautions.

Requirements for female use

Women with reproductive potential must undergo a pregnancy test before starting treatment, and can only use it if the result is negative. During treatment, pregnancy should be checked monthly and reliable contraceptive measures should be taken. If you are pregnant or suspected of being pregnant, you should stop taking the drug immediately and seek medical attention. Ambrisentan may cause harm to the fetus and is contraindicated for pregnant women.

Effects of male use

Ambrisentan may reduce sperm count and affect male fertility. Male patients who are planning to have children should consult a doctor to assess the potential effects of the drug on fertility. If relevant problems arise during treatment, they should communicate with the doctor in a timely manner.

Patients should have regular follow-up visits to monitor the efficacy and adverse reactions of the drug. When storing the drug, it should be placed in the original packaging and kept at a temperature of 20°C to 25°C, avoiding humid or high temperature environments. If you have any questions, you can contact your doctor or pharmacist for further guidance.